Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 520

1.

High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study.

Kinlay S, Schwartz GG, Olsson AG, Rifai N, Leslie SJ, Sasiela WJ, Szarek M, Libby P, Ganz P; Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering Study Investigators.

Circulation. 2003 Sep 30;108(13):1560-6. Epub 2003 Sep 15.

PMID:
12975259
[PubMed - indexed for MEDLINE]
Free Article
2.

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial.

Schwartz GG, Olsson AG, Ezekowitz MD, Ganz P, Oliver MF, Waters D, Zeiher A, Chaitman BR, Leslie S, Stern T; Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators.

JAMA. 2001 Apr 4;285(13):1711-8.

PMID:
11277825
[PubMed - indexed for MEDLINE]
3.

Inflammation, statin therapy, and risk of stroke after an acute coronary syndrome in the MIRACL study.

Kinlay S, Schwartz GG, Olsson AG, Rifai N, Szarek M, Waters DD, Libby P, Ganz P; Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators.

Arterioscler Thromb Vasc Biol. 2008 Jan;28(1):142-7. Epub 2007 Nov 8.

PMID:
17991875
[PubMed - indexed for MEDLINE]
Free Article
4.

Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study.

Kinlay S, Schwartz GG, Olsson AG, Rifai N, Sasiela WJ, Szarek M, Ganz P, Libby P; Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators.

Circulation. 2004 Jul 27;110(4):386-91. Epub 2004 Jul 19.

PMID:
15262833
[PubMed - indexed for MEDLINE]
Free Article
5.

Atorvastatin has an important acute anti-inflammatory effect in patients with acute coronary syndrome: results of a randomized, double-blind, placebo-controlled study.

Macin SM, Perna ER, Farías EF, Franciosi V, Cialzeta JR, Brizuela M, Medina F, Tajer C, Doval H, Badaracco R.

Am Heart J. 2005 Mar;149(3):451-7.

PMID:
15864233
[PubMed - indexed for MEDLINE]
6.

Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.

Bonnet J, McPherson R, Tedgui A, Simoneau D, Nozza A, Martineau P, Davignon J; CAP Investigators.

Clin Ther. 2008 Dec;30(12):2298-313. doi: 10.1016/j.clinthera.2008.12.023.

PMID:
19167589
[PubMed - indexed for MEDLINE]
7.

Anti-inflammatory effect of atorvastatin (80 mg) in unstable angina pectoris and non-Q-wave acute myocardial infarction.

Correia LC, Spósito AC, Lima JC, Magalhães LP, Passos LC, Rocha MS, D'Oliveira A, Esteves JP.

Am J Cardiol. 2003 Aug 1;92(3):298-301.

PMID:
12888137
[PubMed - indexed for MEDLINE]
8.

High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial.

Tsimikas S, Witztum JL, Miller ER, Sasiela WJ, Szarek M, Olsson AG, Schwartz GG; Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators.

Circulation. 2004 Sep 14;110(11):1406-12. Epub 2004 Sep 7.

PMID:
15353498
[PubMed - indexed for MEDLINE]
Free Article
9.

Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial.

Ray KK, Cannon CP, Cairns R, Morrow DA, Rifai N, Kirtane AJ, McCabe CH, Skene AM, Gibson CM, Ridker PM, Braunwald E; PROVE IT-TIMI 22 Investigators.

J Am Coll Cardiol. 2005 Oct 18;46(8):1417-24.

PMID:
16226164
[PubMed - indexed for MEDLINE]
Free Article
10.

The effect of early statin treatment on inflammation and cardiac events in acute coronary syndrome patients with low-density lipoprotein cholesterol.

Kanadaşi M, Cayli M, Demirtaş M, Inal T, Demir M, Koç M, Avkaroğullari M, Dönmez Y, Usal A, Alhan CC, San M.

Heart Vessels. 2006 Sep;21(5):291-7. Epub 2006 Sep 29.

PMID:
17151816
[PubMed - indexed for MEDLINE]
11.

Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial.

Fraley AE, Schwartz GG, Olsson AG, Kinlay S, Szarek M, Rifai N, Libby P, Ganz P, Witztum JL, Tsimikas S; MIRACL Study Investigators.

J Am Coll Cardiol. 2009 Jun 9;53(23):2186-96. doi: 10.1016/j.jacc.2009.02.041.

PMID:
19497447
[PubMed - indexed for MEDLINE]
Free Article
12.

Correlation between inflammation and oxidative stress in normocholesterolemic coronary artery disease patients 'on' and 'off' atorvastatin for short time intervals.

Thomas MK, Narang D, Lakshmy R, Gupta R, Naik N, Maulik SK.

Cardiovasc Drugs Ther. 2006 Feb;20(1):37-44.

PMID:
16534549
[PubMed - indexed for MEDLINE]
13.

High-dose statin and COX-2 inhibitor therapy rapidly decreases C-reactive protein level in patients with unstable angina.

Chyrchel M, Dudek D, Bartuś S, Legutko J, Heba G, Dubiel JS.

Kardiol Pol. 2004 Sep;61(9):213-21; discussion 222-4. English, Polish.

PMID:
15531933
[PubMed - indexed for MEDLINE]
14.

[Non-ST-elevation acute coronary syndrome. Comparison of effects of atorvastatin and rosuvastatin on blood levels of lipids and markers of inflammation].

Kuznetsova MA, Vaulin NA, Masenko VP, Gratsianskiĭ NA.

Kardiologiia. 2010;50(2):21-5. Russian.

PMID:
20146674
[PubMed - indexed for MEDLINE]
15.

Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study.

Pasceri V, Patti G, Nusca A, Pristipino C, Richichi G, Di Sciascio G; ARMYDA Investigators.

Circulation. 2004 Aug 10;110(6):674-8. Epub 2004 Jul 26.

PMID:
15277322
[PubMed - indexed for MEDLINE]
Free Article
16.

Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.

Strandberg TE, Feely J, Sigurdsson EL; DISCOVERY study group.

Clin Ther. 2004 Nov;26(11):1821-33.

PMID:
15639694
[PubMed - indexed for MEDLINE]
17.

High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial.

Pedersen TR, Faergeman O, Kastelein JJ, Olsson AG, Tikkanen MJ, Holme I, Larsen ML, Bendiksen FS, Lindahl C, Szarek M, Tsai J; Incremental Decrease in End Points Through Aggressive Lipid Lowering (IDEAL) Study Group.

JAMA. 2005 Nov 16;294(19):2437-45. Erratum in: JAMA. 2005 Dec 28;294(24):3092.

PMID:
16287954
[PubMed - indexed for MEDLINE]
18.

Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial.

Ray KK, Cannon CP, McCabe CH, Cairns R, Tonkin AM, Sacks FM, Jackson G, Braunwald E; PROVE IT-TIMI 22 Investigators.

J Am Coll Cardiol. 2005 Oct 18;46(8):1405-10.

PMID:
16226162
[PubMed - indexed for MEDLINE]
Free Article
19.

Re-elevation of high-sensitivity C-reactive protein but not the von Willebrand Factor after withdrawing atorvastatin therapy in patients with unstable angina undergoing coronary artery stenting.

Yip HK, Youssef AA, Chua S, Hung WC, Chen YH, Yeh KH, Wu CJ, Hang CL.

Int Heart J. 2006 Jul;47(4):501-9.

PMID:
16960405
[PubMed - indexed for MEDLINE]
Free Article
20.

Effect of intensive lipid-lowering therapy on mortality after acute coronary syndrome (a patient-level analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 trials).

Murphy SA, Cannon CP, Wiviott SD, de Lemos JA, Blazing MA, McCabe CH, Califf RM, Braunwald E.

Am J Cardiol. 2007 Oct 1;100(7):1047-51. Epub 2007 Jul 18.

PMID:
17884359
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk